Publications
Overview of Host Defense Peptides and Their Applications for Plastic and Reconstructive Surgeons
DeLong, MR,
Tandon, VJ,
Da Lio, AL,
Deming, TJ,
Cederna, PS,
Plast Reconstr Surg, 2020 Jul; DOI:10.1097/PRS.0000000000006910 Novel role of ASH1L histone methyltransferase in anaplastic thyroid carcinoma
Xu, B,
Qin, T,
Yu, J,
Giordano, TJ,
Sartor, MA,
Koenig, RJ,
J Biol Chem, 2020 Jun; DOI:10.1074/jbc.RA120.013530 The role of the histone H3 variant CENPA in prostate cancer
Saha, AK,
Contreras-Galindo, R,
Niknafs, YS,
Iyer, M,
Qin, T,
Padmanabhan, K,
Siddiqui, J,
Palande, M,
Wang, C,
Qian, B,
Ward, E,
Tang, T,
Tomlins, SA,
Gitlin, SD,
Sartor, MA,
Omenn, GS,
Chinnaiyan, AM,
Markovitz, DM,
J Biol Chem, 2020 Jun; DOI:10.1074/jbc.RA119.010080 Abstract B19: Malnutrition evaluation in head and neck cancer patients: Practice patterns among otolaryngologists and radiation oncologists
Gill, AS,
Kinzinger, M,
Moore, MG,
Clinical Cancer Research, 2020 Jun; DOI:10.1158/1557-3265.aacrahns19-b19 Abstract B07: High-risk human papillomavirus association with oropharyngeal squamous cell carcinoma in Taiwan
Hiles, GL,
Wang, C-I,
Pinatti, LM,
Goudsmit, CM,
Peters, L,
Briggs, HL,
Thomas, TB,
Charara, M,
Khatib, RA,
Afsari, MA,
Morris, AC,
Jawad, N,
Som, D,
Chang, K-P,
Carey, TE,
Walline, HM,
Clinical Cancer Research, 2020 Jun; DOI:10.1158/1557-3265.aacrahns19-b07 Abstract B17: Functional characterization of HPV-human fusion transcripts in oropharyngeal cancer
Pinatti, LM,
Walline, HM,
Carey, TE,
Clinical Cancer Research, 2020 Jun; DOI:10.1158/1557-3265.aacrahns19-b17 Abstract B32: Impact of cancer-associated fibroblasts on head and neck cancer stem cells
Neal, MEH,
Owen, JHJ,
Spector, ME,
Carey, TE,
Prince, MEP,
Chinn, SB,
Clinical Cancer Research, 2020 Jun; DOI:10.1158/1557-3265.aacrahns19-b32 Enhanced mitochondrial fission suppresses signaling and metastasis in triple-negative breast cancer
Humphries, BA,
Cutter, AC,
Buschhaus, JM,
Chen, Y-C,
Qyli, T,
Palagama, DSW,
Eckley, S,
Robison, TH,
Bevoor, A,
Chiang, B,
Haley, HR,
Sahoo, S,
Spinosa, PC,
Neale, DB,
Boppisetti, J,
Sahoo, D,
Ghosh, P,
Lahann, J,
Ross, BD,
Yoon, E,
Luker, KE,
Luker, GD,
Breast Cancer Res, 2020 Jun; DOI:10.1186/s13058-020-01301-x Primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel (OLYMPUS): an open-label, single-arm, phase 3 trial
Kleinmann, N,
Matin, SF,
Pierorazio, PM,
Gore, JL,
Shabsigh, A,
Hu, B,
Chamie, K,
Godoy, G,
Hubosky, S,
Rivera, M,
O'Donnell, M,
Quek, M,
Raman, JD,
Knoedler, JJ,
Scherr, D,
Stern, J,
Weight, C,
Weizer, A,
Woods, M,
Kaimakliotis, H,
Smith, AB,
Linehan, J,
Coleman, J,
Humphreys, MR,
Pak, R,
Lifshitz, D,
Verni, M,
Adibi, M,
Amin, MB,
Seltzer, E,
Klein, I,
Konorty, M,
Strauss-Ayali, D,
Hakim, G,
Schoenberg, M,
Lerner, SP,
Lancet Oncol, 2020 Jun; DOI:10.1016/S1470-2045(20)30147-9 A path to improve colorectal cancer screening outcomes: Faculty roundtable evaluation of cost-effectiveness and utility
Bone, RH,
Cross, JD,
Dwyer, AJ,
Fox, JL,
Hyams, DM,
Hassmiller Lich, K,
Mackey, TA,
Miller, RM,
Fendrick, AM,
Am J Manag Care, 2020 Jun; DOI:10.37765/ajmc.2020.43732 Memory CD8<sup>+</sup> T cell responses to cancer
Han, J,
Khatwani, N,
Searles, TG,
Turk, MJ,
Angeles, CV,
Semin Immunol, 2020 Jun; DOI:10.1016/j.smim.2020.101435 Intraobserver variability in bladder cancer treatment response assessment with and without computerized decision support
Hadjiiski, LM,
Cha, KH,
Cohan, RH,
Chan, H-P,
Caoili, EM,
Davenport, MS,
Samala, RK,
Weizer, AZ,
Alva, A,
Kirova-Nedyalkova, G,
Shampain, K,
Meyer, N,
Barkmeier, D,
Woolen, SA,
Shankar, PR,
Francis, IR,
Palmbos, PL,
Tomography, 2020 Jun; DOI:10.18383/j.tom.2020.00013 Incidence and impact of Textbook Outcome among patients undergoing resection of pancreatic neuroendocrine tumors: Results of the US Neuroendocrine Tumor Study Group
Heidsma, CM,
Hyer, M,
Tsilimigras, DI,
Rocha, F,
Abbott, DE,
Fields, R,
Smith, PM,
Poultsides, GA,
Cho, C,
Maithel, SK,
Pawlik, TM,
Other Members of the US Neuroendocrine Tumor Study Group, Array,
J Surg Oncol, 2020 Jun; DOI:10.1002/jso.25900 Functional imaging in ectopic Cushing syndrome
Grigoryan, S,
Avram, AM,
Turcu, AF,
Curr Opin Endocrinol Diabetes Obes, 2020 Jun; DOI:10.1097/MED.0000000000000541 Finding the Nearest TRexit: Novel Transperineal Prostate Biopsy Approaches for All Practices
Wang, RS,
Doerge, E,
Wei, JT,
Ellimoottil, C,
Herrel, L,
Stork, B,
Montie, J,
Raisky, J,
Ferrante, S,
Linsell, S,
Miller, DC,
George, A,
Videourology, 2020 Jun; Parathyroid cancer: An update
Rodrigo, JP,
Hernandez-Prera, JC,
Randolph, GW,
Zafereo, ME,
Hartl, DM,
Silver, CE,
Suárez, C,
Owen, RP,
Bradford, CR,
Mäkitie, AA,
Shaha, AR,
Bishop, JA,
Rinaldo, A,
Ferlito, A,
Cancer Treat Rev, 2020 Jun; DOI:10.1016/j.ctrv.2020.102012 PAX8 expression and TERT promoter mutations in the nested variant of urothelial carcinoma: a clinicopathologic study with immunohistochemical and molecular correlates
Taylor, AS,
McKenney, JK,
Osunkoya, AO,
Chan, MP,
Al-Ahmadie, HA,
Spratt, DE,
Fullen, DR,
Chinnaiyan, AM,
Brown, NA,
Mehra, R,
Mod Pathol, 2020 Jun; DOI:10.1038/s41379-020-0453-z Assessment of task-based performance from five clinical DBT systems using an anthropomorphic breast phantom
Ikejimba, LC,
Salad, J,
Graff, CG,
Goodsitt, M,
Chan, HP,
Zhao, W,
Ghammraoui, B,
Lo, JY,
Glick, SH,
Proc. SPIE, 2020 May; Differential modulation of the androgen receptor for prostate cancer therapy depends on the DNA response element
Kregel, S,
Bagamasbad, P,
He, S,
LaPensee, E,
Raji, Y,
Brogley, M,
Chinnaiyan, A,
Cieslik, M,
Robins, DM,
Nucleic Acids Res, 2020 May; DOI:10.1093/nar/gkaa178 Clinical efficacy of ONC201 in thalamic H3 K27M-mutant glioma.
Kawakibi, AR,
Tarapore, R,
Gardner, SL,
Kurz, SC,
Wen, PY,
Arrillaga-Romany, I,
Batchelor, T,
Butowski, NA,
Sumrall, AL,
Shonka, NA,
Harrison, RA,
De Groot, JF,
Mehta, MP,
Odia, Y,
Hall, MD,
Cloughesy, TF,
Ellingson, BM,
Umemura, Y,
Allen, JE,
Koschmann, CJ,
Journal of Clinical Oncology, 2020 May; DOI:10.1200/jco.2020.38.15_suppl.3617 Association of prior immune checkpoint blockade (ICB) with longer progression-free survival (PFS) in patients treated with intermittent versus continuous dabrafenib and trametinib: A post-hoc analysis of S1320.
Algazi, AP,
Othus, M,
Daud, A,
Mehnert, JM,
Truong, T-G,
Conry, RM,
Kendra, KL,
Doolittle, GC,
Clark, JI,
Messino, MJ,
Moore, DF,
Lao, CD,
Faller, BA,
Govindarajan, R,
Harker-Murray, AK,
Dreisbach, LP,
Moon, J,
Grossmann, KF,
Lo, R,
Ribas, A,
Journal of Clinical Oncology, 2020 May; DOI:10.1200/jco.2020.38.15_suppl.10039 DCE-MRI Evaluation of 10 patients with brain metastases treated with RRx-001, a Myc inhibitor and a CD47 and PD-L1 downregulator, in a phase I/II trial called BRAINSTORM.
Kim, MM,
Parmar, H,
Aryal, MP,
Caroen, S,
Devasia, T,
Schipper, MJ,
Morikawa, A,
Spratt, DE,
Hayman, J,
Junck, L,
Lawrence, TS,
Lao, CD,
Cao, Y,
Journal of Clinical Oncology, 2020 May; DOI:10.1200/jco.2020.38.15_suppl.e14509 Clinical outcomes in patients with BRAF V600 mutant melanoma and undetectable circulating tumor DNA treated with dabrafenib and trametinib.
Algazi, AP,
Othus, M,
Voorhies, BN,
Kendra, KL,
Dakhil, SR,
Harker-Murray, AK,
Lao, CD,
Chmielowski, B,
Lo, R,
Grossmann, KF,
Ribas, A,
Journal of Clinical Oncology, 2020 May; DOI:10.1200/jco.2020.38.15_suppl.10059 Toxicities with combination BRAF and MEK inhibition in resected stage III melanoma.
Warrier, G,
Homan, M,
Lao, CD,
Yentz, SE,
Kraft, S,
Fecher, LA,
Journal of Clinical Oncology, 2020 May; DOI:10.1200/jco.2020.38.15_suppl.e22086 Use of immune checkpoint inhibitors (ICIs) after prior ICI in metastatic renal cell carcinoma (mRCC): Results from a multicenter collaboration.
Ravi, P,
Mantia, C,
Su, C,
Sorenson, K,
Rathi, N,
Bakouny, Z,
Agarwal, N,
Costello, BA,
McKay, RR,
Narayan, V,
Alva, AS,
McGregor, BA,
Gao, X,
McDermott, DF,
Choueiri, TK,
Journal of Clinical Oncology, 2020 May; DOI:10.1200/jco.2020.38.15_suppl.5077 